Canna Capital PLC

Canna Capital is an investment company that focuses on identifying and pursuing opportunities in the medical cannabis sector. The company invests in assets such as research and development and intellectual properties.
  • Investment in medical cannabis
  • Research and development in cannabis
  • Acquisition of intellectual properties

Size
Small
Phone
+44 (0)20 3468 6323
Email
N/A
Locations
85 Great Portland St, W1W 7LT
9:00 - 17:00
Digital Popularity
Social Media
Competitors
Frontier Botanics
Frontier Botanics is a pioneering company in the medical cannabis sector, focusing on natural healing through the cultivation, extraction, and distribution of cannabis products.
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry (ABPI) represents companies of all sizes that invest in discovering and developing medicines and vaccines.
Apposite Capital
Apposite Capital is a healthcare impact investor in Europe, dedicated to growing healthcare companies through strategic support and a network of senior advisors.
NG Bio
NG Bio Ltd is an early-stage longevity investor and venture builder focused on extending health span by addressing harmful immune responses that contribute to major human diseases.
Company Details
Canna Capital PLC is operated by Canna Capital Plc and is a Liquidation company incorporated on 1 April 2021 with the registered office located in London, Greater London. Canna Capital Plc was registered 4 years ago.

Status
Liquidation
Size
Micro
Directors
6
Age
4 years old
Employees
Unreported
Turnover
Unreported
Total Assets
£507.05K
Cash in Bank
£341.21K
Total Liabilities
-£53.28K

Director • British • Born in Jul 1950
Director • British • Lives in England • Born in Jan 1995
Director • Head Of Cultivation/Medical Cannabis Industry • British • Lives in UK • Born in Jun 1970
Director • British • Lives in England • Born in Jan 1968
Director • Company Director And Reg Medical Practitioner • British • Lives in England • Born in Nov 1943
Teams
All
1
Chief Executive Officer • Joined Apr 2021